AJP - Regu AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 285: R429-R437, 2003. First published May 8, 2003; doi:10.1152/ajpregu.00176.2003
0363-6119/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/R429    most recent
00176.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reidelberger, R. D.
Right arrow Articles by Hulce, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reidelberger, R. D.
Right arrow Articles by Hulce, M.

APPETITE, OBESITY AND METABOLISM

Effects of peripheral CCK receptor blockade on food intake in rats

Roger D. Reidelberger,1,2 Daniel A. Castellanos,1,2 and Martin Hulce3

1Department of Veterans Affairs Nebraska Western Iowa Health Care System, Omaha 68105; and Departments of 2Biomedical Sciences and 3Chemistry, Creighton University, Omaha, Nebraska 68178

Submitted 3 April 2003 ; accepted in final form 2 May 2003

Type A cholecystokinin receptor (CCKAR) antagonists differing in blood-brain barrier permeability were used to test the hypothesis that satiety is mediated, in part, by CCK action at CCKARs located peripheral to the blood-brain barrier. At dark onset, non-food-deprived rats received a bolus injection of devazepide (2.5 µmol/kg iv), a 3-h infusion of A-70104 (1 or 3 µmol·kg-1·h-1 iv), or vehicle either alone or coadministered with a 3-h infusion of CCK-8 (10 nmol·kg-1·h-1 iv) or a 2-h intragastric infusion of peptone (1 g/h). Food intake was determined from continuous computer recordings of changes in food bowl weight. Devazepide penetrates the blood-brain barrier; A-70104, the dicyclohexylammonium salt of N{alpha}-3-quinolinoyl-D-Glu-N,N-dipentylamide (A-65186), does not. CCK-8 inhibited 3-h food intake by more than 50% and both A-70104 and devazepide abolished this response. A-70104 and devazepide stimulated food intake and similarly attenuated the anorexic response to intragastric infusion of peptone. Thus endogenous CCK appears to act, in part, at CCKARs peripheral to the blood-brain barrier to inhibit food intake.

receptor antagonist; devazepide; A-70104; satiety



Address for reprint requests and other correspondence: R. D. Reidelberger, VA-NWIHCS (151), 4101 Woolworth Ave., Omaha, NE 68105 (E-mail: Roger.Reidelberger{at}med.va.gov).




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. L. Whited, D. Thao, K. C. K. Lloyd, A. S. Kopin, and H. E. Raybould
Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function
Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G156 - G162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Sartor, A. Shulkes, and A. J. M. Verberne
An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R625 - R633.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. A. Cupples
Physiological regulation of food intake
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1438 - R1443.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. Weikard, C. Kuhn, T. Goldammer, G. Freyer, and M. Schwerin
The bovine PPARGC1A gene: molecular characterization and association of an SNP with variation of milk fat synthesis
Physiol Genomics, March 21, 2005; 21(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. D. Reidelberger, J. Hernandez, B. Fritzsch, and M. Hulce
Abdominal vagal mediation of the satiety effects of CCK in rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1005 - R1012.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Burdyga, S. Lal, A. Varro, R. Dimaline, D. G. Thompson, and G. J. Dockray
Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin
J. Neurosci., March 17, 2004; 24(11): 2708 - 2715.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.